Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of
Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of Imation, such as the company's medical imaging business, which includes dry printers, x-ray film, and PACS operations.
Speculation about a possible deal has surfaced on online investment boards and was rife on the exhibit floor at last month's American Healthcare Radiology Administrator's meeting in Las Vegas. Representatives from both Kodak and Imation said that as a matter of corporate policy the companies do not comment on rumors.
If Kodak did buy Imation's medical imaging business, the deal would give Kodak an even stronger position in the x-ray film and PACS markets. Rumors about Kodak have proven wrong in the past, however. Speculation late last year that Kodak would sell its medical imaging business to Johnson & Johnson proved to be untrue (SCAN 1/21/98).
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.